Pages with the fewest revisions
Jump to navigation
Jump to search
Showing below up to 50 results in range #46,701 to #46,750.
- ATP5E (3 revisions)
- ATP5F1 (3 revisions)
- ATP5G1 (3 revisions)
- ATP5I (3 revisions)
- ATP5J2 (3 revisions)
- ATP5L (3 revisions)
- ATP5O (3 revisions)
- ATP6AP1 (3 revisions)
- ATP6V0B (3 revisions)
- ATP6V0D2 (3 revisions)
- ATP6V1B1 (3 revisions)
- ATP6V1G2 (3 revisions)
- ATP synthase (3 revisions)
- ATRX (3 revisions)
- AVERT Trial (3 revisions)
- AVNRT primary prevention (3 revisions)
- AV junctional rhythms (3 revisions)
- AXL receptor tyrosine kinase (3 revisions)
- Abacavir lamivudine clinical pharmacology (3 revisions)
- Abacavir lamivudine zidovudine (3 revisions)
- Abacavir lamivudine zidovudine drug interactions (3 revisions)
- Abacavir lamivudine zidovudine indications and usage (3 revisions)
- Abacavir overdosage (3 revisions)
- Abarelix (3 revisions)
- Abbreviations (3 revisions)
- Abderhalden-Kaufmann-Lignac syndrome historical perspective (3 revisions)
- Abdominal angina natural history, complications and prognosis (3 revisions)
- Abdominal angina physical examination (3 revisions)
- Abdominal angina primary prevention (3 revisions)
- Abdominal aortic aneurysm CT scan (3 revisions)
- Abdominal aortic aneurysm laboratory findings (3 revisions)
- Abdominal aortic aneurysm other diagnostic studies (3 revisions)
- Abdominal bruit other imaging findings (3 revisions)
- Abdominal distension case study one (3 revisions)
- Abdominal distension cost-effectiveness of therapy (3 revisions)
- Abdominal distension future or investigational therapies (3 revisions)
- Abdominal enlargement (3 revisions)
- Abdominal epilepsy (3 revisions)
- Abdominal hair (3 revisions)
- Abdominal pain, nausea,vomiting and GI bleeding (3 revisions)
- Abdominal wall defect (3 revisions)
- Abelin reaction (3 revisions)
- Abiraterone acetate (3 revisions)
- Abl gene (3 revisions)
- Ablepharon macrostomia syndrome (3 revisions)
- Abnormal posturing pathophysiology (3 revisions)
- Abnormal uterine bleeding case study one (3 revisions)
- Abrocitinib (3 revisions)
- Abrupt closure and no-reflow case 1 (3 revisions)
- Abrupt closure case 28 (3 revisions)